Stockreport

GLP-1 Anti-Obesity U.S. Drug Market In Four Charts [zero hedge]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF GLP-1 Anti-Obesity U.S. Drug Market In Four Charts Beyond the most recent GLP-1 feud between Hims & Hers and Novo Nordisk, UBS analysts shift attention to anti-obesity d [Read more]